BUFFER CAPACITY OF ANTIBODIES

摘要

The invention concerns the field of biomolecule formulations. It concerns a liquid formulation of therapeutic antibodies at high concentrations for pharmaceutical use including the purpose of storage and administration to patients. Based on this formulation the antibodies are in an aqueous solution that buffers changes in p H in absence of a buffer excipient.